Intratumoral TLR-4 Agonist Injection Is Critical for Modulation of Tumor Microenvironment and Tumor Rejection

about

In situ vaccination for the treatment of cancer.

P2860

Q38727470-13223EA9-E0C7-4388-801E-EDA086F82E60

P2860

Intratumoral TLR-4 Agonist Injection Is Critical for Modulation of Tumor Microenvironment and Tumor Rejection

Item

http://www.wikidata.org/entity/Q58905402

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2012

@uk

name

Intratumoral TLR-4 Agonist Inj ...... nvironment and Tumor Rejection

@en

Intratumoral TLR-4 Agonist Inj ...... nvironment and Tumor Rejection

@nl

type

Item

label

Intratumoral TLR-4 Agonist Inj ...... nvironment and Tumor Rejection

@en

Intratumoral TLR-4 Agonist Inj ...... nvironment and Tumor Rejection

@nl

prefLabel

Intratumoral TLR-4 Agonist Inj ...... nvironment and Tumor Rejection

@en

Intratumoral TLR-4 Agonist Inj ...... nvironment and Tumor Rejection

@nl

P1476

Intratumoral TLR-4 Agonist Inj ...... nvironment and Tumor Rejection

@en

P2093

Ana Paula Duarte de Souza

http://www.w3.org/2001/XMLSchema#string

Archie Bouwer

http://www.w3.org/2001/XMLSchema#string

Cristina Bonorino

http://www.w3.org/2001/XMLSchema#string

David Hinrichs

http://www.w3.org/2001/XMLSchema#string

Fabio Luiz Dal Moro Maito

http://www.w3.org/2001/XMLSchema#string

Luciana Pereira

http://www.w3.org/2001/XMLSchema#string

Megan Smithey

http://www.w3.org/2001/XMLSchema#string

P2860

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Initial T cell frequency dictates memory CD8+ T cell lineage commitment.

The role of MHC class I glycoproteins in the regulation of induction of cell death in immunocytes by malignant melanoma cells.

The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.

NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer.

Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens.

Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces.

The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity.

A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5402/2012/926817

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

Toll-like receptor

Intratumoral TLR-4 Agonist Injection Is Critical for Modulation of Tumor Microenvironment and Tumor Rejection

about

P2860

P2860

Intratumoral TLR-4 Agonist Injection Is Critical for Modulation of Tumor Microenvironment and Tumor Rejection

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P921